204 related articles for article (PubMed ID: 29542252)
21. USP4 regulates TUT1 ubiquitination status in concert with SART3.
Kim J; Taketomi T; Yamada A; Uematsu Y; Ueda K; Chiba T; Tsuruta F
Biochem Biophys Res Commun; 2024 Mar; 701():149557. PubMed ID: 38310689
[TBL] [Abstract][Full Text] [Related]
22. Curcumin inhibits the development of colorectal cancer via regulating the USP4/LAMP3 pathway.
Wei H; Li X; Liu F; Li Y; Luo B; Huang X; Chen H; Wen B; Ma P
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1749-1762. PubMed ID: 37728623
[TBL] [Abstract][Full Text] [Related]
23. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
24. Increased Expression of Ubiquitin-Specific Protease 4 Participates in Neuronal Apoptosis After Intracerebral Hemorrhage in Adult Rats.
Liu C; Liu C; Liu H; Gong L; Tao T; Shen Y; Zhu S; Shen A
Cell Mol Neurobiol; 2017 Apr; 37(3):427-435. PubMed ID: 27114249
[TBL] [Abstract][Full Text] [Related]
25. The Deubiquitinating Enzyme USP4 Functions as an Oncoprotein in Gastric Cancer and Mediates NF-κB Signaling by Regulating PRL-3 Expression.
Tao Y; You W
Front Biosci (Landmark Ed); 2022 Oct; 27(10):286. PubMed ID: 36336860
[TBL] [Abstract][Full Text] [Related]
26. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P
Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.
Wu X; Liu M; Zhu H; Wang J; Dai W; Li J; Zhu D; Tang W; Xiao Y; Lin J; Zhang W; Sun Y; Zhang Y; Chen Y; Li G; Li A; Xiang L; Liu S; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):277. PubMed ID: 31234902
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitously specific protease 4 inhibitor-Vialinin A attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb/mTOR signalling.
Xu J; Chen D; Jin L; Chen Z; Tu Y; Huang X; Xue F; Xu J; Chen M; Wang X; Chen Y
J Cell Mol Med; 2021 Jan; 25(2):1140-1150. PubMed ID: 33295107
[TBL] [Abstract][Full Text] [Related]
29. A20 promotes melanoma progression via the activation of Akt pathway.
Ma J; Wang H; Guo S; Yi X; Zhao T; Liu Y; Shi Q; Gao T; Li C; Guo W
Cell Death Dis; 2020 Sep; 11(9):794. PubMed ID: 32968045
[TBL] [Abstract][Full Text] [Related]
30. Deubiquitinating enzymes USP4 and USP17 finetune the trafficking of PDGFRβ and affect PDGF-BB-induced STAT3 signalling.
Sarri N; Wang K; Tsioumpekou M; Castillejo-López C; Lennartsson J; Heldin CH; Papadopoulos N
Cell Mol Life Sci; 2022 Jan; 79(2):85. PubMed ID: 35064336
[TBL] [Abstract][Full Text] [Related]
31. USP4 positively regulates RLR-induced NF-κB activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication.
Xu C; Peng Y; Zhang Q; Xu XP; Kong XM; Shi WF
Sci Rep; 2018 Sep; 8(1):13418. PubMed ID: 30194441
[TBL] [Abstract][Full Text] [Related]
32. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
[No Abstract] [Full Text] [Related]
33. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.
Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
Melanoma Res; 2019 Dec; 29(6):569-581. PubMed ID: 30889053
[TBL] [Abstract][Full Text] [Related]
35. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
[TBL] [Abstract][Full Text] [Related]
36. USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2.
Chen Y; Guo Y; Yuan M; Guo S; Cui S; Chen D
PLoS One; 2023; 18(8):e0290688. PubMed ID: 37624791
[TBL] [Abstract][Full Text] [Related]
37. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of long noncoding RNA FALEC predicts poor prognosis and promotes melanoma cell proliferation through epigenetically silencing p21.
Ni N; Song H; Wang X; Xu X; Jiang Y; Sun J
Biomed Pharmacother; 2017 Dec; 96():1371-1379. PubMed ID: 29196104
[TBL] [Abstract][Full Text] [Related]
39. Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11.
Vlasschaert C; Xia X; Coulombe J; Gray DA
BMC Evol Biol; 2015 Oct; 15():230. PubMed ID: 26503449
[TBL] [Abstract][Full Text] [Related]
40. Potent USP10/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin.
Guo J; Zhang J; Liang L; Liu N; Qi M; Zhao S; Su J; Liu J; Peng C; Chen X; Liu H
J Cell Mol Med; 2020 Apr; 24(7):4324-4340. PubMed ID: 32129945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
